High-intensity statin on 3-year clinical outcomes in elderly acute myocardial infarction patients underwent percutaneous coronary intervention with drug-eluting stents.

ABSTRACT: There is limited data on high-intensity statin for secondary prevention in elderly acute myocardial infarction (AMI) patients above 75 years. This study aimed to assess the impact of high-intensity statin on 3-year outcomes in elderly AMI patients (> 75 years) who underwent percutaneous coronary intervention (PCI) with drug-eluting stents (DES). From the Korea AMI registry (KAMIR)-National Institutes of Health (NIH), 2,063 elderly patients were divided into three groups based on statin therapy at discharge: high-intensity statin group (n = 521), low/moderate-intensity statin group (n = 1,419), and no statin group (n = 123). The primary endpoint was the 3-year composite of cardiac death and recurrent myocardial infarction (MI). The high-intensity statin group had a similar primary endpoint

SUBMITTER: Her AY 

PROVIDER: S-EPMC12511585 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature